Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the body’s internal organs. Mesothelioma is a difficult disease to study on a global scale for many reasons. Yet, there has been tremendous progress in mesothelioma research over the last decade. However, current cancer guidelines are fragmented. An editorial in the Annals of Oncology recommends that new guidelines need to focus on both global and gender perspectives. Shifting Timeframes Make it Difficult to Study Mesothelioma Cases of mesothelioma are rising in some countries and falling in others. This makes it difficult to study the disease on a global level. There are a few different reasons for this global variation. First, … Continue reading New Cancer Guidelines to Manage and Treat Mesothelioma
Impending changes in the way hospitals are reimbursed for medical treatments may help improve outcomes for some patients with peritoneal mesothelioma. That conclusion comes from a new study in the Annals of Surgical Oncology, which compared the costs with the money a hospital stands to earn from a popular mesothelioma treatment. Mesothelioma is a fast-growing and lethal cancer that occurs most often in people who worked in jobs that exposed them to asbestos. While most cases of mesothelioma occur on the pleura, the lining around the lungs, about a third of cases occur on the peritoneum, which lines the abdomen. Increasingly, the gold standard treatment for people with peritoneal mesothelioma is cytoreductive surgery (CRS) to remove as much of the … Continue reading Optimal Mesothelioma Care: Is Reimbursement Structure a Disincentive?